Abstract
Abstract Consumer vulnerability receives attention in search for effective solutions of complex problems in the social welfare system on the international as well as local or regional scale. Pharmaceutical consumer vulnerability takes various forms and therefore it may be analyzed in social, economic, legal, ecological or purely medical terms. The article presents an integrated methodology that was applied to develop an indicator of pharmaceutical consumption and pharmaceutical consumer vulnerability; it also presents findings of the research, which employed this methodology to estimate vulnerability of different consumer groups as well as general consumer vulnerability in Lithuania, Latvia and Estonia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
